Odysight.ai appoints Nir Nimrodi to board of directors

Odysight.ai Inc.

Nir Nimrodi appointed to board effective August 13, 2023; board determined independent under Nasdaq rules.
Nimrodi is chairman & CEO of Accellix Inc., with over 25 years in life sciences, biotech, and pharma.
Previously served as CBO at Intrexon (Precigen) and VP/GM at Life Technologies (Thermo Fisher).
He holds an MBA from Tel-Aviv University and will receive standard director fees per prior 10-K.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Nir Nimrodi

Director

ODYS · Odysight.ai Inc.

Effective: 2023-08-13
Filed: August 17, 2023, 7:59 PM ET

On August 13, 2023, the Board of Directors of Odysight.ai Inc. (the “Board” and the “Company”, respectively) appointed Mr. Nir Nimrodi to serve as a member of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nir Nimrodi was appointed as Director at Odysight.ai Inc..

Action: appointed
Role: Director

Exact text from the filing

On August 13, 2023, the Board of Directors of Odysight.ai Inc. (the “Board” and the “Company”, respectively) appointed Mr. Nir Nimrodi to serve as a member of the Board.

View on SEC.gov

Odysight.ai Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-029239

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.